[ad_1]
Milan, Italy, Oct. 27, 2022 (GLOBE NEWSWIRE) — AGC Biologics, a number one international Biopharmaceutical Contract Growth and Manufacturing Group (CDMO), at this time introduced it acquired the Excellence in Innovation and Management Award from Italy’s main enterprise new channel, Le Fonti, at an award ceremony on October 6. The corporate was honored for the work of its Milan website, which helps produce cell and gene remedy therapies for Biotech firms for medical and industrial functions.
The ceremony was held on the prestigious location Palazzo Mezzanotte, seat of the Italian Inventory Trade, and noticed AGC Biologics awarded the Excellence in Innovation and Management prize within the Healthcare sector for the management place within the Cell & Gene Remedy sector, its deep technical excellence and the crucial work of the R&D division targeted in bringing revolutionary platforms and options to the market.
The Le Fonti Awards acknowledge excellent organizations and their leaders who reveal company excellence in enterprise innovation, management, technological achievement, and worker engagement. Luca Alberici, Basic Supervisor of the AGC Biologics Milan, was offered the award alongside key members of the Milan website management group.
“We’re honored to simply accept this award and it’s a nice privilege to work with such a robust group of scientists and specialists on the AGC Biologics Milan website,” mentioned Alberici. “Our groups are devoted to bringing new improvements to the sector of cell and gene therapies, and we’re proud to assist create lifesaving therapies with our companions that may affect sufferers all over the world.”
AGC Biologics Milan presents end-to-end companies for cell therapy and viral vector improvement and manufacturing. The ability was additionally the primary GMP facility accredited in Europe for ex-vivo gene remedy manufacturing and has industry-unique industrial manufacturing expertise. Since becoming a member of the AGC Biologics International community in 2020, AGC Biologics invested in improvements to expand its capabilities and manufacturing capacity. The scientists at AGC Biologics Milan have a number of many years of expertise guiding superior remedy merchandise via key product levels, together with growing three industrial merchandise.
To study extra in regards to the AGC Biologics Milan facility and its cell remedy and viral vector companies, go to www.agcbio.com/facilities/milan.
About AGC Biologics
AGC Biologics is a number one international biopharmaceutical Contract Growth and Manufacturing Group (CDMO) with a robust dedication to delivering the very best customary of service as we work side-by-side with our shoppers and companions, each step of the best way. We offer world-class improvement and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our international community spans the U.S., Europe, and Asia, with cGMP-compliant amenities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we at present make use of greater than 2,000 workers worldwide. Our dedication to steady innovation fosters the technical creativity to resolve our shoppers’ most complicated challenges, together with specialization in fast-track initiatives and uncommon ailments. AGC Biologics is the companion of selection. To study extra, go to www.agcbio.com.
[ad_2]
Source link
